Trazodone and venlafaxine in treatment of depressive disorders;Trazodon i wenlafaksyna w leczeniu zaburzeń depresyjnych

Polski Merkuriusz Lekarski

Volumn 18, Issue 107, 2005, Pages 556-559

  Florkowski, Antoni ^a,b   Gruszczyński, Wojciech ^a   Gałecki, Piotr ^a   Zboralski, Krzysztof ^a   Kołodziejska, Izabela ^a   Mikołajczyk, Iwona ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Klinika Psychiatrii i Zaburze Nerwicowych   (Poland)

Author keywords

Depressive disorder; Trazodone; Venlafaxine

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SIDE EFFECT; SYMPTOMATOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; CYCLOHEXANOLS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TRAZODONE; TREATMENT OUTCOME;

EID: 20144369903     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Blacker R., Shanks N.J., Chapman N.: The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin doxepine and amitryptyline. Psychopharmacology, 1998, 95 suppl, 18-24.
2. Cunningham E.A., Borison R.E., Carman J.S.: A comparison of venlafaxine, trazodone and placebo in major depression. J. Clin. Psychopharmacology, 1994, 14, 99-106.
3. Gershon S.: Comparative side effects profile of trazodone and imipramine: special reference to the geriatric population. Psychopathology, 1984, 17 suppl. 2, 39-50.
4. Grof P: The age of misery affective disorder on the rise. Can. J. Psychiatry, 1997, 42, 361-362.
5. Kostowski W., Puzynski S.: Psychofarmakologia kliniczna i doświadczalna. PZWL. Warszawa. 1986.
6. Marek G.J., Mc Dougle C.J., Price L.M.: A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology, 1992, 109, 2-11.
7. Montgomery S.A.: Venlafaxine: A new dimension in antidepressant pharmacotherapy. J. Clin. Psychiatry, 1993, 54, 119-126.
8. Perry P.P., Garvey M.J., Kelly M. W.: A comparative trial of fluoxetine versus trazodone in outpatients with major depression. J. Clin. Psychiatry, 1989, 50, 290-294.
9. Robinson D.S., Corcella J., Feigher J.P.: A comparison of trazodone, amoxepine and maprotiline in the treatment of endogenous depression: results of a multicenter study. Curr. Ther. Res., 1984, 35, 549-560.
10. Weissman M.M., Bland R.C., Canino G.J. iwsp.: Cross-national epidemiology of major depression and bipolar disorder. JAMA, 1996, 276, 293-299.